信邦制药自查补税5078.69万元 公司因涉嫌单位行贿正被起诉

Core Viewpoint - Xinbang Pharmaceutical (002390) announced on January 26 that it needs to pay back taxes and late fees totaling 50.7869 million yuan, which will directly impact its annual profit for 2025 [1] Group 1: Financial Impact - The company itself is responsible for 2.6957 million yuan of the tax and late fees, while its subsidiaries account for 48.0912 million yuan [1] - This expenditure will be recorded in the profit and loss statement for the year 2025, indicating a significant financial burden [1] Group 2: Legal Issues - Earlier in January, the company received a prosecution notice from the People's Procuratorate of Kaiyang County, Guizhou Province, regarding allegations of corporate bribery [1]